Role and molecular mechanisms of SGLT2 inhibitors in pathological cardiac remodeling (Review)
This article reviews the role of SGLT2is in cardiac remodeling induced by different etiologies to provide a guideline for further evaluation of the mechanisms underlying the inhibition of pathological cardiac remodeling by SGLT2is, as well as the development of novel drug targets.PMID:38488029 | PMC:PMC10955520 | DOI:10.3892/mmr.2024.13197
Source: Molecular Medicine Reports - Category: Molecular Biology Authors: Bixian Chen Jing Guo Hongmei Ye Xinyu Wang Yufei Feng Source Type: research
More News: Cardiology | Cardiovascular | Dapagliflozin | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Empagliflozin | Endocrinology | Forxiga | Heart | Heart Failure | Jardiance | Mitochondrial Disease | Molecular Biology | SGLT2 Inhibitors | Study